June 13, 2018

Inozyme Pharma Offers No-Cost Genetic Testing for Rare Calcification Disorders

Read More

Developing new medicines to treat diseases characterized by mineral imbalances in the body

There are over 7,000 rare diseases recognized by the medical community—a disproportionate number of which affect infants and young children. We are singularly focused on developing new, potentially disease-modifying therapies for these children and their families.

Discover How